S100B is expressed in, and released from, OLN-93 oligodendrocytes: Influence of serum and glucose deprivation

Neuroscience

Volumn 154, Issue 2, 2008, Pages 496-503

  Steiner, J ^a   Bernstein, H G ^a   Bogerts, B ^a   Gos, T ^a,b   Richter Landsberg, C ^c   Wunderlich, M T ^a   Keilhoff, G ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c UNIVERSITY OF OLDENBURG   (Germany)

Author keywords

astrocytes; oligodendrocytes; OLN 93; RAGE; S 100B; S100 beta

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; PROTEIN S100B;

ANIMAL CELL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; IMMUNOLOCALIZATION; METABOLIC STRESS; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN SECRETION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CELL LINE, TUMOR; CELLS, CULTURED; COLORING AGENTS; CULTURE MEDIA, SERUM-FREE; FLUORESCEINS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE; IMMUNOHISTOCHEMISTRY; NERVE GROWTH FACTORS; OLIGODENDROGLIA; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; S100 PROTEINS;

EID: 46549086821     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.03.060     Document Type: Article

References (45)

1. Bianchi R., Verzini M., Garbuglia M., Giambanco I., and Donato R. Mechanism of S100 protein-dependent inhibition of glial fibrillary acidic protein (GFAP) polymerization. Biochim Biophys Acta 1223 (1994) 354-360
2. de Almeida L.M., Pineiro C.C., Leite M.C., Brolese G., Tramontina F., Feoli A.M., Gottfried C., and Goncalves C.A. Resveratrol increases glutamate uptake, glutathione content, and S100B secretion in cortical astrocyte cultures. Cell Mol Neurobiol 27 (2007) 661-668
3. Deloulme J.C., Raponi E., Gentil B.J., Bertacchi N., Marks A., Labourdette G., and Baudier J. Nuclear expression of S100B in oligodendrocyte progenitor cells correlates with differentiation toward the oligodendroglial lineage and modulates oligodendrocytes maturation. Mol Cell Neurosci 27 (2004) 453-465
4. Dietrich M.O., Tort A.B., Schaf D.V., Farina M., Goncalves C.A., Souza D.O., and Portela L.V. Increase in serum S100B protein level after a swimming race. Can J Appl Physiol 28 (2003) 710-716
5. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33 (2001) 637-668
6. Dyck R.H., Van Eldik L.J., and Cynader M.S. Immunohistochemical localization of the S-100 beta protein in postnatal cat visual cortex: spatial and temporal patterns of expression in cortical and subcortical glia. Brain Res Dev Brain Res 72 (1993) 181-192
7. Gerlach R., Demel G., Konig H.G., Gross U., Prehn J.H., Raabe A., Seifert V., and Kogel D. Active secretion of S100B from astrocytes during metabolic stress. Neuroscience 141 (2006) 1697-1701
8. Griffin W.S., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White III C.L., and Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A 86 (1989) 7611-7615
9. Hachem S., Aguirre A., Vives V., Marks A., Gallo V., and Legraverend C. Spatial and temporal expression of S100B in cells of oligodendrocyte lineage. Glia 51 (2005) 81-97
10. Keilhoff G., and Wolf G. Comparison of double fluorescence staining and LDH-test for monitoring cell viability in vitro. Neuroreport 5 (1993) 129-132
11. Leite M.C., Brolese G., de Almeida L.M., Pinero C.C., Gottfried C., and Goncalves C.A. Ammonia-induced alteration in S100B secretion in astrocytes is not reverted by creatine addition. Brain Res Bull 70 (2006) 179-185
12. Lins H., Wallesch C.W., and Wunderlich M.T. Sequential analyses of neurobiochemical markers of cerebral damage in cerebrospinal fluid and serum in CNS infections. Acta Neurol Scand 112 (2005) 303-308
13. Margis R., Zanatto V.C., Tramontina F., Vinade E., Lhullier F., Portela L.V., Souza D.O., Dalmaz C., Kapczinski F., and Goncalves C.A. Changes in S100B cerebrospinal fluid levels of rats subjected to predator stress. Brain Res 1028 (2004) 213-218
14. Moore B., and Perez V.J. Specific acidic proteins of the nervous system. In: Carlson F.D. (Ed). Physiological and biochemical aspects of nervous integration (1967), Prentice-Hall, Englewood Cliffs, NJ 343-359
15. Moore B.W. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 19 (1965) 739-744
16. Mrak R.E., Sheng J.G., and Griffin W.S. Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J Neuropathol Exp Neurol 55 (1996) 273-279
17. Nardin P., Tramontina F., Leite M.C., Tramontina A.C., Quincozes-Santos A., de Almeida L.M., Battastini A.M., Gottfried C., and Goncalves C.A. S100B content and secretion decrease in astrocytes cultured in high-glucose medium. Neurochem Int 50 (2007) 774-782
18. Netto C.B., Conte S., Leite M.C., Pires C., Martins T.L., Vidal P., Benfato M.S., Giugliani R., and Goncalves C.A. Serum S100B protein is increased in fasting rats. Arch Med Res 37 (2006) 683-686
19. Nowotny M., Spiechowicz M., Jastrzebska B., Filipek A., Kitagawa K., and Kuznicki J. Calcium-regulated interaction of Sgt1 with S100A6 (calcyclin) and other S100 proteins. J Biol Chem 278 (2003) 26923-26928
20. Pelinka L.E., Kroepfl A., Leixnering M., Buchinger W., Raabe A., and Redl H. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. J Neurotrauma 21 (2004) 1553-1561
21. Peskind E.R., Griffin W.S., Akama K.T., Raskind M.A., and Van Eldik L.J. Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease. Neurochem Int 39 (2001) 409-413
22. Piazza O., Cotena S., Esposito G., De Robertis E., and Tufano R. S100B is a sensitive but not specific prognostic index in comatose patients after cardiac arrest. Minerva Chir 60 (2005) 477-480
23. Pinto S.S., Gottfried C., Mendez A., Goncalves D., Karl J., Goncalves C.A., Wofchuk S., and Rodnight R. Immunocontent and secretion of S100B in astrocyte cultures from different brain regions in relation to morphology. FEBS Lett 486 (2000) 203-207
24. Ponath G., Schettler C., Kaestner F., Voigt B., Wentker D., Arolt V., and Rothermundt M. Autocrine S100B effects on astrocytes are mediated via RAGE. J Neuroimmunol 184 (2007) 214-222
25. Richter-Landsberg C., and Heinrich M. S-100 immunoreactivity in rat brain glial cultures is associated with both astrocytes and oligodendrocytes. J Neurosci Res 42 (1995) 657-665
26. Richter-Landsberg C., and Heinrich M. OLN-93: a new permanent oligodendroglia cell line derived from primary rat brain glial cultures. J Neurosci Res 45 (1996) 161-173
27. Rickmann M., and Wolff J.R. S100 immunoreactivity in a subpopulation of oligodendrocytes and Ranvier's nodes of adult rat brain. Neurosci Lett 186 (1995) 13-16
28. Romero-Aleman Mdel M., Monzon-Mayor M., Yanes C., Arbelo-Galvan J.F., Lang D., Renau-Piqueras J., and Negrin-Martinez C. S100 immunoreactive glial cells in the forebrain and midbrain of the lizard Gallotia galloti during ontogeny. J Neurobiol 57 (2003) 54-66
29. Routsi C., Stamataki E., Nanas S., Psachoulia C., Stathopoulos A., Koroneos A., Zervou M., Jullien G., and Roussos C. Increased levels of serum S100B protein in critically ill patients without brain injury. Shock 26 (2006) 20-24
30. Savola O., Pyhtinen J., Leino T.K., Siitonen S., Niemela O., and Hillbom M. Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. J Trauma 56 (2004) 1229-1234
31. Scaccianoce S., Del Bianco P., Pannitteri G., and Passarelli F. Relationship between stress and circulating levels of S100B protein. Brain Res 1004 (2004) 208-211
32. Schroeter M.L., Abdul-Khaliq H., Diefenbacher A., and Blasig I.E. S100B is increased in mood disorders and may be reduced by antidepressive treatment. Neuroreport 13 (2002) 1675-1678
33. Schulpis K.H., Moukas M., Parthimos T., Tsakiris T., Parthimos N., and Tsakiris S. The effect of alpha-tocopherol supplementation on training-induced elevation of S100B protein in sera of basketball players. Clin Biochem 40 (2007) 900-906
34. Sheng J.G., Mrak R.E., and Griffin W.S. S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques. J Neurosci Res 39 (1994) 398-404
35. Steiner J., Bernstein H.G., Bielau H., Berndt A., Brisch R., Mawrin C., Keilhoff G., and Bogerts B. Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neurosci 8 (2007) 2
36. Steiner J., Bernstein H.G., Bielau H., Farkas N., Winter J., Dobrowolny H., Brisch R., Gos T., Mawrin C., Myint A.M., and Bogerts B. S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: A morphometric study. J Psychiatr Res (2007) online [doi:10.1016/j.jpsychires.2007.10.001]
37. Steiner J., Bielau H., Bernstein H.G., Bogerts B., and Wunderlich M.T. Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones. J Neurol Neurosurg Psychiatry 77 (2006) 1284-1287
38. Toth C., Schmidt A.M., Tuor U.I., Francis G., Foniok T., Brussee V., Kaur J., Yan S.F., Martinez J.A., Barber P.A., Buchan A., and Zochodne D.W. Diabetes, leukoencephalopathy and rage. Neurobiol Dis 23 (2006) 445-461
39. Tramontina F., Leite M.C., Goncalves D., Tramontina A.C., Souza D.F., Frizzo J.K., Nardin P., Gottfried C., Wofchuk S.T., and Goncalves C.A. High glutamate decreases S100B secretion by a mechanism dependent on the glutamate transporter. Neurochem Res 31 (2006) 815-820
40. Unden J., Bellner J., Eneroth M., Alling C., Ingebrigtsen T., and Romner B. Raised serum S100B levels after acute bone fractures without cerebral injury. J Trauma 58 (2005) 59-61
41. van Eldik L.J., and Griffin W.S. S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions. Biochim Biophys Acta 1223 (1994) 398-403
42. van Eldik L.J., and Wainwright M.S. The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor Neurol Neurosci 21 (2003) 97-108
43. van Eldik L.J., and Zimmer D.B. Secretion of S-100 from rat C6 glioma cells. Brain Res 436 (1987) 367-370
44. Vives V., Alonso G., Solal A.C., Joubert D., and Legraverend C. Visualization of S100B-positive neurons and glia in the central nervous system of EGFP transgenic mice. J Comp Neurol 457 (2003) 404-419
45. Wunderlich M.T., Wallesch C.W., and Goertler M. Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke. J Neurol Sci 227 (2004) 49-53